BILLINGS KBEAR WEATHER

Health

FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots


Go to Source
Author:

thebear

May 5th, 2022

No comments

Comments are closed.